NORGES BANK - CHINA BIOLOGIC PRODS INC ownership

CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 161 filers reported holding CHINA BIOLOGIC PRODS INC in Q3 2016. The put-call ratio across all filers is 1.47 and the average weighting 0.5%.

Quarter-by-quarter ownership
NORGES BANK ownership history of CHINA BIOLOGIC PRODS INC
ValueSharesWeighting
Q2 2017$27,727,000
+16.4%
245,151
+3.1%
0.01%
+10.0%
Q1 2017$23,819,000
-2.1%
237,885
+5.1%
0.01%
-9.1%
Q4 2016$24,340,000
-9.6%
226,3780.0%0.01%
-15.4%
Q3 2016$26,915,000
+22.6%
226,378
+9.7%
0.01%
+30.0%
Q2 2016$21,947,000
+15.5%
206,428
+24.3%
0.01%
+11.1%
Q1 2016$19,004,000
-2.0%
166,007
+22.0%
0.01%
-10.0%
Q4 2015$19,390,000
+417.8%
136,107
+226.4%
0.01%
+400.0%
Q3 2015$3,745,00041,7000.00%
Other shareholders
CHINA BIOLOGIC PRODS INC shareholders Q3 2016
NameSharesValueWeighting ↓
WARBURG PINCUS LLC 10,989,200$1,049,578,0007.88%
RUDMAN ERROL M 110,201$10,525,0003.65%
Ativo Capital Management LLC 59,789$5,710,0002.24%
OBERWEIS ASSET MANAGEMENT INC/ 56,200$5,368,0001.51%
Granite Point Capital Management, L.P. 40,000$3,820,0001.40%
Cormorant Asset Management, LP 76,500$7,307,0001.13%
Spark Investment Management LLC 52,800$5,031,0000.70%
Grandeur Peak Global Advisors, LLC 33,050$3,157,0000.67%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 198,454$18,954,0000.66%
Visium Asset Management, LP 438,008$41,834,0000.62%
View complete list of CHINA BIOLOGIC PRODS INC shareholders